100’000 Medacta stems implanted worldwide, 70000 are AMIS! And the beginning of the Medacta business in the Japanese and Brasilian orthopaedic market.
 |
JOA Medacta® will be present at the JOA17th - 20th May, 2012 Kyoto, Japan www.joa2012.jp |
AMIS Hip and MyKnee Arthroplasty Update 2012 International Symposium 31st May - 2nd June, 2012Pörtschach am Wörthersee, Austria |
EFORT Medacta® will be present at the EFORT23rd - 25th May, 2012 Berlin, Germany www.efort.org/ |
100th AMIS M.O.R.E. LEARNING CENTER Medacta® leadership in education of the anterior minimally invasive approach. |
President's corner Medacta® between innovation and communication.
|
IT WORKS! Proven accuracy and effectiveness of MyKnee, patient matched cutting blocks In 2009 Medacta® International launched MyKnee®, patient matched cutting blocks for knee replacement. Since then, several articles have been published on MyKnee® proving the two main benefits of patient matched technology: accuracy and effectiveness.
|
Medacta: supports your practice Medacta® has created a number of patient oriented documents and marketing tools to support you in the promotion of your practice and activity towards the patient.
|
VERSAFITCUP DM: the effective design to prevent dislocation The Versafitcup® Double Mobility has a cup design that provides effective hip stability and has produced better theoretical results than other designs on the market, considering the jumping distance as predictive factor.
|
AMIS: Market Leader Worldwide for the Anterior Approach AMIS®, strengthened by several years of clinical experience, provides the highest standard of service and innovation with regard to the anterior approach.
|
